“Drug Survival of Risankizumab Vs Other Biologics After 25 Months of Treatment Among Patients With Psoriatic Arthritis: An Interim Analysis of the VALUE Study”. SKIN The Journal of Cutaneous Medicine 9, no. 6 (November 10, 2025): s695. Accessed May 2, 2026. https://skin.dermsquared.com/skin/article/view/3825.